Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 165 results
Author [ Title(Asc)] Year
Filters: Author is Aplenc, Richard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Hagleitner MM, Coenen MJH, Aplenc R, et al. "The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer." Pharmacogenomics J.. 2014;14(2):115-9.
Winestone LE, Getz KD, Miller TP, et al. "The Role of Acuity of Illness at Presentation in Early Mortality in Black Children with Acute Myeloid Leukemia." Am. J. Hematol.. 2016.
Pan Y, Kadash-Edmondson KE, Wang R, et al. "RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets." Trends Pharmacol Sci. 2021;42(4):268-282.
Kadauke S, Myers RM, Li Y, et al. "Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial." J Clin Oncol. 2021:JCO2002477.
Elgarten CW, Otto WR, Shenton L, et al. "Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia." Infect Control Hosp Epidemiol. 2022:1-8.
Kotch C, Avery R, Getz KD, et al. "Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1." Neuro Oncol. 2022.
Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R. "Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study." Pediatr Blood Cancer. 2010;55(4):655-61.
Desai AV, Li Y, Getz K, et al. "Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database." Pediatr Blood Cancer. 2018:e27372.
Desai AV, Seif AE, Li Y, et al. "Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database." Pediatr Blood Cancer. 2016;63(5):901-7.
Yi JS, Chambers TM, Getz KD, et al. "A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment." Haematologica. 2022.

Pages